• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gram-negative septicemia in patients with hematologic malignancies.

作者信息

Todeschini G, Vinante F, Benini F, Perini A, Pasini F, Cetto G

出版信息

Eur J Cancer Clin Oncol. 1984 Mar;20(3):327-31. doi: 10.1016/0277-5379(84)90077-4.

DOI:10.1016/0277-5379(84)90077-4
PMID:6368245
Abstract

The clinical records of 66 consecutive episodes of Gram-negative bacteremia occurring in 60 patients with hematologic malignancies during a 66-month period were reviewed to assess the major prognostic factors. The bacteremia-related mortality was 53%. Overall, Pseudomonas aeruginosa (54%) and Escherichia coli (24%) were the predominant isolates (fatality rate 78 and 31% respectively). The majority of patients (58/66) were granulocytopenic (PMN less than 1000/microliters). Among the 18 patients whose circulating granulocytes increased by one log10 or to above 1000/mmc during therapy, the fatality rate was 39%, as opposed to 70% in the 40 patients without such an increase. Pneumonia-associated bacteremia (56%) had a high fatality rate (73%) compared to isolated bacteremias (27%). Septic shock and inappropriate antibiotic therapy accounted for the highest mortality. Our data suggest that Pseudomonas etiology, persistent neutropenia, associated pneumonia, septic shock and inappropriate antibiotic therapy account for a bad prognosis in Gram-negative bacteremia in hematologic malignancies.

摘要

相似文献

1
Gram-negative septicemia in patients with hematologic malignancies.
Eur J Cancer Clin Oncol. 1984 Mar;20(3):327-31. doi: 10.1016/0277-5379(84)90077-4.
2
[Bacterial septicemia in neutropenia patients].[中性粒细胞减少患者的细菌性败血症]
Ann Med Interne (Paris). 1983;134(7):629-35.
3
Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.铜绿假单胞菌血症:133例病例中影响预后因素的单因素及多因素分析
Rev Infect Dis. 1988 May-Jun;10(3):629-35. doi: 10.1093/clinids/10.3.629.
4
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.127例血液系统恶性肿瘤中性粒细胞减少患者铜绿假单胞菌血症的预后改善
Int J Infect Dis. 1998;3(2):99-104. doi: 10.1016/s1201-9712(99)90017-6.
5
Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.头孢噻肟联合阿米卡星作为经验性治疗用于血液系统恶性肿瘤中性粒细胞减少患者发热性疾病的治疗。
Infection. 1985 May-Jun;13(3):125-9. doi: 10.1007/BF01642871.
6
Current concepts of bacteremia in children with malignancies.儿童恶性肿瘤患者菌血症的当前概念。
Cancer. 1979 Nov;44(5):1939-44. doi: 10.1002/1097-0142(197911)44:5<1939::aid-cncr2820440557>3.0.co;2-l.
7
SOME OBSERVATIONS ON BACTEREMIA DUE TO GRAM-NEGATIVE BACILLI.关于革兰氏阴性杆菌所致菌血症的一些观察
SD J Med Pharm. 1964 Sep;17:22-30.
8
Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.血液系统恶性肿瘤合并铜绿假单胞菌感染患者发生感染性休克的危险因素。
Hematology. 2011 May;16(3):160-5. doi: 10.1179/102453311X12953015767293.
9
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.氟喹诺酮类预防性用药对中性粒细胞减少症和血液系统恶性肿瘤患者感染相关死亡率降低的影响。
Clin Infect Dis. 2005 Apr 15;40(8):1087-93. doi: 10.1086/428732. Epub 2005 Mar 11.
10
Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients.
Eur J Cancer Clin Oncol. 1988;24 Suppl 1:S47-54.

引用本文的文献

1
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.发热性中性粒细胞减少症儿童和青少年铜绿假单胞菌血症的临床特征、结局及抗生素耐药性的影响:一项回顾性研究
BMC Infect Dis. 2017 Jul 17;17(1):500. doi: 10.1186/s12879-017-2597-0.
2
Nosocomial septicemias due to methicillin-resistant staphylococcus aureus and Pseudomonas aeruginosa in a university hospital over a 12-year period--the same intractable infections.一所大学医院12年间耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌所致的医院败血症——同样棘手的感染。
Infection. 1996 May-Jun;24(3):238-41. doi: 10.1007/BF01781100.
3
Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.
用鲁米诺增强化学发光法测定多克隆免疫球蛋白对多形核白细胞对肠炎沙门氏菌脂多糖反应的影响。
Infect Immun. 1994 Oct;62(10):4320-4. doi: 10.1128/iai.62.10.4320-4324.1994.
4
Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.抗O特异性脂多糖免疫球蛋白G抗体对实验性大肠杆菌感染的保护水平评估。
Infect Immun. 1993 Mar;61(3):975-80. doi: 10.1128/iai.61.3.975-980.1993.
5
[Septicemia in leukemia and malignant lymphoma. Incidence pathogens--causes].[白血病和恶性淋巴瘤中的败血症。发病率、病原体——病因]
Klin Wochenschr. 1985 Sep 2;63(17):821-6. doi: 10.1007/BF01732287.
6
Empiric treatment of infection during granulocytopenia: a comprehensive approach.粒细胞减少症期间感染的经验性治疗:一种综合方法。
Infection. 1989 Mar-Apr;17(2):59-64. doi: 10.1007/BF01646877.
7
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.大肠杆菌O18 O-多糖结合疫苗的合成与表征
Infect Immun. 1990 Feb;58(2):373-7. doi: 10.1128/iai.58.2.373-377.1990.